In the Authorship section on page 2928 in the 4 October 2012 issue, the conflict-of-interest statement should read, “D.P. owns stock options in and serves as an unpaid scientific advisor for Tempest Therapeutics. The remaining authors declare no competing financial interests.”

Sign in via your Institution